MEGA GENOMICS (06667) released its interim results, with revenue reaching 192 million yuan, a significant year-on-year increase of 136.8%.
Meigen Gene (06667) announced its results for the six months ended June 30, 2026. The group achieved revenue of 192 million yuan, a year-on-year increase of 136.8%; gross profit of 63.678 million yuan, a year-on-year increase of 5.9%; and net profit of 24.751 million yuan, with earnings per share of 0.12 yuan.
MEGA GENOMICS (06667) announced its results for the six months ending June 30, 2026, reporting revenues of 192 million yuan, a year-on-year increase of 136.8%; gross profit of 63.678 million yuan, an increase of 5.9%; and a net profit of 24.751 million yuan, with earnings per share of 0.12 yuan.
The announcement stated that revenue saw significant growth during the reporting period, primarily due to the group's continued expansion of product categories, improvement of product matrix layout, and optimization of overall business structure. Multiple coordinated initiatives effectively drove a steady increase in overall revenue scale.
Related Articles
.png)
XINGDA INT'L (01899) released its interim results, with profit attributable to shareholders of 65 million yuan, a decrease of 67.3% compared to the same period last year.
EDDING GENOR (06998) Chairman Ni Xin plans to invest up to $1 million to increase his shareholding in the company.
JF SMARTINVEST (09636) 2026 Mid-term Performance Report: Practicing AI Technology's Comprehensive Strategy, Building a Closed Loop for Investment Advisory Services
XINGDA INT'L (01899) released its interim results, with profit attributable to shareholders of 65 million yuan, a decrease of 67.3% compared to the same period last year.
EDDING GENOR (06998) Chairman Ni Xin plans to invest up to $1 million to increase his shareholding in the company.
JF SMARTINVEST (09636) 2026 Mid-term Performance Report: Practicing AI Technology's Comprehensive Strategy, Building a Closed Loop for Investment Advisory Services
RECOMMEND
